A case of partial anomalous pulmonary venous drainage with intact interatrial septum associated with mitral stenosis is reported. The roentgenogram showed plethora confined to the anomalously draining ...

All data were organized in a table presented as authors, year of publication, country, type of study, sample size, mean age, sex, follow-up time, time for reoperation, mortality, mitral stenosis, New ...

Aortic stenosis is the most common adult heart valve condition seen in the Western world and its incidence continues to rise. No established disease modifying treatments retard progression of the ...

Patients with rheumatic mitral stenosis (MS), insufficient echocardiographic data for MAC assessment, or prior mitral intervention were excluded. We initially selected 212 patients who received follow ...

Addition of revascularization to optimized medical therapy was not beneficial in patients with carotid stenosis ≥50% and low or intermediate predicted stroke risk. HealthDay News — For patients with ...

Exclusion criteria were contraindications to TEE, uncontrolled atrial fibrillation, mitral stenosis, moderate-to-severe aortic valve disease, moderate-to-severe tricuspid regurgitation or associated ...

Cutting-edge MRI technology can diagnose a common heart problem more quickly and accurately than ever before Aortic stenosis is a progressive and potentially fatal condition, affecting an estimated ...

FDA Approves SAPIEN 3 Platform for Asymptomatic Severe Aortic Stenosis By Lori Solomon HealthDay ReporterMONDAY, May 5, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved ...

Congenital supravalvular mitral stenosis is a rare malformation characterized by the presence of a shelf-like fibrous membrane, with 1 or 2 small orifices, covering and obstructing the mitral valve.

THE effects of mitral stenosis on the heart and lungs are due to an obstructive lesion between the left atrium and ventricle. The bodily response to such an obstruction is initially twofold.

FDA approved the Sapien 3 transcatheter aortic valve replacement (TAVR) platform for treatment of severe aortic stenosis early in the disease process while patients still had no symptoms or other ...

Asymptomatic patients with severe aortic stenosis can now undergo transcatheter aortic valve replacement, thanks to the US Food and Drug Administration’s approval of the new indication for the balloon ...